|
Jaw-Wen Chen, M.D. |
Education: |
-
Doctor of Medicine
Kaohsiung Medical University School of Medicine,
Kaohsiung, Taiwan, Republic of China
-
Post-doctoral Research Fellowship, Vascular medicine & biology,
Stanford University School of Medicine,
Folk Cardiovascular Research Center, Stanford, California, USA
|
................................................................................................................................. |
Current Positions: |
- Contributing Physician, Taipei Veterans General Hospital
|
|
............................................................................................................................................................................................... |
Faculty: |
- Distinguish Professor School of Medicine, National Yang Ming Chiao Tung University School of Medicine, Taipei, Taiwan, Republic of China
- Professor (Join appointment) Institute of Pharmacology and Institute of Emergency, and Critical Care Medicine, National Yang-Ming University University School of Medicine, Taipei, Taiwan, Republic of China
|
............................................................................................................................................................................................... |
Experience:
|
-
Republic of China
Clinical Research Fellowship: 1991 - 1993
Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Republic of China
Attending Physician: 1993 - 2009
Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Republic of China
Board and Exacutive Secretary, 2009 - 2010
Institutional Review Board (IRB),
Taipei Veterans General Hospital, Republic of China
Professor and Director,
Division of Clinical Skills Training, 2009 - 2013
Department of Medical Research and Education, Taipei Veterans General Hospital, Republic of China
Board and Exacutive Secretary, 2010 - 2015
1st Institutional Review Board (IRB1),
Taipei Veterans General Hospital, Republic of China
Professor and Director,
Division of Clinical Research, 2013
Department of Medical Research
Taipei Veterans General Hospital, Republic of China
|
............................................................................................................................................................................................... |
Specialist Certificate: |
- License of physician, Taiwan
- License of Cardiology, Taiwan
|
.............................................................................................................................................................................................. |
Medical Expertise: |
- Atherosclerosis
- Coronary artery disease and coronary intervention
- Hypertension
- Angiogenesis and endothelial progenitor cells
- Genetics and pharrmaco-genetics of cardiovascular diseases
|
............................................................................................................................................................................................... |
E-mail: |
|
.............................................................................................................................................................................................. |
Important Publication: |
- Chang TT, Lin LY, Chen JW*. Inhibition of macrophage inflammatory protein-1β improves endothelial progenitor cell function and ischemia-induced angiogenesis in diabetes. Angiogenesis. 2019; 22(1):53-65.
- Hsu CY, Tseng WK, Wu YW, Lin TH, Yeh HI, Chang KC, Wang JH, Chou RH, Huang CY, Huang PH, Leu HB*, Yin WH, Wu CC, Lin SJ, Chen JW*. Circulating TNFSf14 (tumor necrosis factor superfamily 14) predicts clinical outcome in patients with stable coronary artery disease. Arterioscler Thromb Vasc Biol. 2019 ;39(6):1240–1252.
- Chang TT, Chen JW*. Hydralazine improves ischemia-induced neovasculogenesis viaxanthine-oxidase inhibition in chronic renal insufficiency. Pharmacol Res. 2020;151:104509.
- Huang CC, Chang MT, Leu HB, Yin WH, Tseng WK, Wu YW, Lin TH, Yeh HI, Chang KC, Wang JH, Wu CC, Shyur LF*, Chen JW*. Association of arachidonic acid-derived lipid mediators with subsequent onset of acute myocardial infarction in patients with coronary artery disease. Sci Rep. 2020;10(1):8105.
- Chang TT, Chiang CH, Chen C, Lin SC, Lee HJ, Chen JW*. Antioxidation and Nrf2-mediated heme oxygenase-1 activation contribute to renal protective effects of hydralazine in diabetic nephropathy. Biomed. Pharmacother. 2022; 151: 113139.
限於篇幅,以上謹為代表著作
|
|